Combination Estrogen–Progestin Oral Contraceptives
- 9 October 2003
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 349 (15) , 1443-1450
- https://doi.org/10.1056/nejmcp030751
Abstract
A healthy, sexually active, 35-year-old woman presents for advice about the use of oral contraceptives. She does not smoke cigarettes and has no personal or family history of venous thromboembolism, myocardial infarction, or stroke. Her blood pressure is 120/80 mm Hg. Should an oral contraceptive be prescribed, and if so, how should a formulation be chosen?Keywords
This publication has 59 references indexed in Scilit:
- Family history of cancer, oral contraceptive use, and ovarian cancer riskAmerican Journal of Obstetrics and Gynecology, 2002
- Low-dose oral contraceptives: Protective effect on ovarian cancer riskInternational Journal of Cancer, 2001
- Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2MutationNew England Journal of Medicine, 2001
- Oral Contraceptives: Current StatusClinical Obstetrics and Gynecology, 2001
- Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleedingObstetrics & Gynecology, 2000
- Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral ContraceptivesAmerican Journal of Epidemiology, 2000
- Effect of low-dose oral contraceptives on androgenic markers and acneContraception, 1999
- Contraceptive Failure Rates: New Estimates from the 1995 National Survey of Family GrowthFamily Planning Perspectives, 1999
- Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementationAnnals of Hematology, 1998
- Oral Contraceptives and the Risk of Hereditary Ovarian CancerNew England Journal of Medicine, 1998